• Markets
    • icon
  • Companies
BDX · ASX

BCAL Diagnostics Limited (ASX:BDX)

AU$0.1

 0.0 (0.0%)
ASX:Live
06/12/2023 03:30:44 PM
HALO Ords GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BDX Overview

BDX Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About BDX

Website

N/A

Telephone

N/A

Address

Description

BCAL Diagnostics Ltd. develops screening tests for the early detection of breast cancer. It also associated lipids, biomarker blood test that is used for prevention, screening and monitoring. The company was founded by Jayne Shaw and Ron Philips in 2010 and is headquartered in Sydney, Australia.

BDX Price Chart

Key Stats

Market Cap

AU$25.16M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.05 - 0.21

Trade Value (12mth)

AU$4,519.00

1 week

0%

1 month

-4.76%

YTD

53.85%

1 year

42.86%

All time high

0.275

Key Fundamentals

EPS 3 yr Growth

650.000%

EBITDA Margin

N/A

Operating Cashflow

-$6m

Free Cash Flow Return

-76.80%

ROIC

-64.30%

Interest Coverage

-485.40

Quick Ratio

2.70

Other Data

Shares on Issue (Fully Dilluted)

212m

HALO Sector

Healthcare

Next Company Report Date

27-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

BDX Announcements

Latest Announcements

Date Announcements

31 October 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

31 October 22

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

31 January 22

Becoming a substantial holder

×

Becoming a substantial holder

30 June 23

Proposed issue of securities - BDX

×

Proposed issue of securities - BDX

30 June 23

Notification regarding unquoted securities - BDX

×

Notification regarding unquoted securities - BDX

30 August 23

Share Purchase Plan Offer Booklet

×

Share Purchase Plan Offer Booklet

30 August 23

Preliminary Final Report

×

Preliminary Final Report

30 August 22

Preliminary Final Report

×

Preliminary Final Report

29 September 23

Appendix 4G & Corporate Governance Statement

×

Appendix 4G & Corporate Governance Statement

29 September 23

Annual Report to shareholders

×

Annual Report to shareholders

29 September 22

Annual Report to shareholders

×

Annual Report to shareholders

29 September 22

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

29 November 23

Collaboration with KIMS & Indo-American Hospitals Hyderabad

×

Collaboration with KIMS & Indo-American Hospitals Hyderabad

29 November 22

BCAL AGM Presentation

×

BCAL AGM Presentation

29 November 22

Results of Meeting

×

Results of Meeting

29 December 21

Application for quotation of securities - BDX

×

Application for quotation of securities - BDX

29 August 23

Proposed issue of securities - BDX

×

Proposed issue of securities - BDX

29 August 22

Application for quotation of securities - BDX

×

Application for quotation of securities - BDX

28 September 21

Annual Report to shareholders

×

Annual Report to shareholders

28 October 22

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

28 October 22

Letter to Shareholders on Annual General Meeting Notice

×

Letter to Shareholders on Annual General Meeting Notice

28 November 23

Change in substantial holding

×

Change in substantial holding

28 November 23

Director Change of Interest Notices X 4

×

Director Change of Interest Notices X 4

28 June 22

BCAL Enters US Product Development Agreement with Precion

×

BCAL Enters US Product Development Agreement with Precion

28 July 23

Shares and Options Released from Escrow

×

Shares and Options Released from Escrow

28 July 23

Application for quotation of securities - BDX

×

Application for quotation of securities - BDX

28 July 22

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

28 August 23

$2.4m Capital Raise to Further BREASTEST Commercialisation

×

$2.4m Capital Raise to Further BREASTEST Commercialisation

BDX Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.01 -0.02 -0.02 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.01 -0.02 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -121.9 -133.8 -44.6 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.02 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.02 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock -144.2 -131.8 -53.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A -19.9 -43.4 Lock Lock Lock
DPS $ Lock Lock Lock Lock N/A 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock N/A 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.02 0.05 0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.02 0.05 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock 721.8 177.2 -47.2 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 215 204 211 Lock Lock Lock
Basic m Lock Lock Lock Lock 215 204 211 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 2 4 8 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 100.0 N/A -451.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -2 -4 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -59.2 -126.8 -90.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -2 -4 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -58.1 -128.0 -92.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -2 -4 -8 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 -1 -3 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -2 -3 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock -119.0 -122.0 -49.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -1 -3 -6 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 -4 4 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 4 9 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -1 -3 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -81.9 -168.1 -97.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 3 10 3 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 4 11 8 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -3 -10 -2 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1 1 3 Lock Lock Lock
Equity $m Lock Lock Lock Lock 4 10 5 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 4 10 6 Lock Lock Lock
     Growth % Lock Lock Lock Lock 388.1 167.3 -36.6 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -36.9 -32.0 -60.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -42.3 -35.1 -97.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -82.8 -62.0 -99.3 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -70.2 -51.1 -64.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -55.5 -48.6 -76.8 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A -485.4 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.9 2.3 0.3 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -94.5 -99.3 -40.5 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 7.9 11.0 2.7 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 7.9 11.0 2.7 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 82.5 91.5 51.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -229.5 -338.7 -267.5 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -36.9 -32.0 -60.5 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.1 1.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -42.3 -35.1 -97.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock N/A 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock N/A -35.1 -97.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock N/A 4,673.5 2,984.5 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock N/A -4,673.5 -2,984.5 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BDX Shortsell

Frequently Asked Questions

The current share price of BCAL Diagnostics Limited (BDX:ASX) is AU$0.1.
The 52-week high share price for BCAL Diagnostics Limited (BDX:ASX) is AU$0.21.
The 52-week low share price for BCAL Diagnostics Limited (BDX:ASX)? is AU$0.05.
BCAL Diagnostics Limited (BDX:ASX) does not pay a dividend.
BCAL Diagnostics Limited (BDX:ASX) does not pay a dividend.
BCAL Diagnostics Limited (BDX:ASX) has a franking level of 0%.
BCAL Diagnostics Limited (BDX:ASX) is classified in the Healthcare.
The current P/E ratio for BCAL Diagnostics Limited (BDX:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.